Page 168 - Neuropsychiatric.indd

30. Vandael E, Vandenberk B, Vandenberghe J, Spriet I, Willems R, Foulon V. Development of 44. Yuan M, Tse G, Zhang Z, Han X, Wu WKK, Li G, et al. The incidence of atrial fibrillation with
a risk score for QTc-prolongation: the RISQ-PATH study. Int J Clin Pharm. 2017;39(2):424- trastuzumab treatment: A systematic review and meta-analysis. Cardiovasc Ther. 2018

32. ;36(6):e12475.
31. Haugaa KH, Bos JM, Tarrell RF, Morlan BW, Caraballo PJ, Ackerman MJ. Institution-wide QT 45. สมาคมแพทย์โรคหัวใจแห่งประเทศไทยในพระบรมราชูปถัมภ์. แนวทางเวชปฏิบัติส าหรับดูแลผู้ป่วยภาวะ
alert system identifies patients with a high risk of mortality. Mayo Clin Proc. 2013;88(4):315- หัวใจเต้นผิดจังหวะชนิด atrial fibrillation (AF) ในประเทศไทย. กรงเทพมหานคร: บริษัท ศรีเมืองการ
ุ
25. พิมพ์ จ ากัด, 2555.

32. Tisdale risk score for QT prolongation. [accessed 29 November 2020]. Available from: 46. Okuyan H. Diclofenac induced paroxysmal atrial fibrillation. Emerg Med Case Rep 2018;
https://www.mdcalc.com/tisdale-risk-score-qt-prolongation 9(4): 80-2.
33. Khatib R, Sabir FRN, Omari C, Pepper C, Tayebjee MH. Managing drug-induced QT 47. Zhao D, Chen J, Liu X, Long X, Cao L, Wang J. Atrial fibrillation following treatment with

prolongation in clinical practice. Postgrad Med J. 2021;97(1149):452-8. paclitaxel: a case report. Biomedical reports. 2018;9:540-4.
34. Lexi-drugs online. Lexicomp, Inc.; 2021 [accessed 20 February 2021]. Available from: 48. สมาคมพษวิทยาคลินิก. ยาต้านพิษ ๒. กรุงเทพมหานคร: บริษัท ศรีเมืองการพิมพ์ จ ากัด, 2555.
ิ
http://online.lexi.com. Subscription required to view. 49. Tandeter H, Kobal S, Katz A. Swallowing-induced atrial tachyarrhythmia triggered by
35. Thomas SH, Behr ER. Pharmacological treatment of acquired QT prolongation and torsades salbutamol: case report and review of the literature. Clin Cardiol. 2010;33(6):E116-20.
de pointes. Br J Clin Pharmacol. 2016;81(3):420-7. 50. Bibas L, Levi M, Essebag V. Diagnosis and management of supraventricular tachycardias.

36. Arce JS, Rubén Romero, Paula Solorzano. A case of prolonged QT Interval and torsades de CMAJ. 2016;188(17-18):E466-73.
pointes due to ciprofloxacin. Rev Esp Cardiol. 2010;63(1):111-25. 51. Kim SJ, Gim MS. Clozapine-related paroxysmal supraventricular tachycardia: a case report.
37. Ayad RF, Assar MD, Simpson L, Garner JB, Schussler JM. Causes and management of drug- East Asian Arch Psychiatry. 2018;28(2):68-70.

induced long QT syndrome. Proc (Bayl Univ Med Cent). 2010;23(3):250–5. 52. Kusumoto FM, Schoenfeld MH, Barrett C, Edgerton JR, Ellenbogen KA, Gold MR, et al. 2018
38. Donthi N, Chandrabhatla T, Genovese L, deFilippi C. Fast and furious: flecainide toxicity ACC/AHA/HRS Guideline on the evaluation and management of patients with bradycardia
presenting as monomorphic ventricular tachycardia. BMJ Case Rep 2020;13:e236932. and cardiac conduction delay: Executive Summary: A Report of the American College of
39. Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ, et al. 2015 ACC/AHA/HRS Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the

Guideline for the management of adult patients with supraventricular tachycardia: Heart Rhythm Society. J Am Coll Cardiol. 2019;74(7):932-87.
executive summary: A report of the American College of Cardiology/American Heart 53. Stewart K. Drug-induced bradycardia. Adverse Drug Reaction Bulletin;2011(269):1035-38.
Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. 54. Isik AT, Soysal P, Stubbs B, Solmi M, Basso C, Maggi S, et al. Cardiovascular outcomes of
Circulation. 2016;133(14):e471-505. cholinesterase inhibitors in individuals with dementia: A meta-analysis and systematic

40. Brugada J, Katritsis DG, Arbelo E, Arribas F, Bax JJ, Blomström-Lundqvist C, et al. 2019 ESC review. J Am Geriatr Soc. 2018;66(9):1805-11.
Guidelines for the management of patients with supraventricular tachycardia The Task 55. Patel AA, White CM, Gillespie EL, Kluger J, Coleman CI. Safety of amiodarone in the
Force for the management of patients with supraventricular tachycardia of the European prevention of postoperative atrial fibrillation: a meta-analysis. Am J Health Syst Pharm.
Society of Cardiology (ESC). Eur Heart J. 2020;41(5):655-720. 2006;63(9):829-37.

41. Tisdale JE. Chapter 26 Supraventricular arrhythmia. In: Tisdale JE et al., eds. Drug-Induced 56. Calvo-Romero JM, Lima-Rodriguez EM. Bradycardia associated with ophthalmic beta-
Diseases: Prevention, Detection, and Management. 3rd ed. United States: American Society blockers. J Postgrad Med. 2003;49:186.
of Health-System Pharmacists, Inc., 2018. 57. Takeuchi S, Kotani Y, Tsujimoto T. Hypotension induced by the concomitant use of a
42. Kaakeh Y, Overholser BR, Lopshire JC, Tisdale JE. Drug-induced atrial fibrillation. Drugs. calcium-channel blocker and clarithromycin. BMJ Case Rep. 2017;2017:bcr2016218388.

2012;72(12):1617-30. 58. Carteolol ophthalmic solution. [accessed 29 November 2020]. Available from:
43. Tamargo J, Caballero R, Delpon E. Drug-induced atrial fibrillation. Expert Opin Drug Saf https://www.drugs.com/pro/carteolol.html
2012;11(4):615-34. 59. Timolol ophthalmic solution. [accessed 29 November 2020]. Available from:
https://www.drugs.com/monograph/timolol-eent.html

146 147
147